51. Scleroderma Clinical trials / Disease details
Clinical trials : 525 / Drugs : 565 - (DrugBank : 148) / Drug target genes : 114 - Drug target pathways : 217
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-UMIN000026859 | 2017/04/10 | 05/04/2017 | Effectiveness of therapy with acotinamide hydrochloride and Trimebutine Maleateon gastro-oesophagial disease in systemic sclerosis | Effectiveness of therapy with acotinamide hydrochloride and Trimebutine Maleateon gastro-oesophagial disease in systemic sclerosis - Therapy with acotinamide hydrochloride and Trimebutine Maleateon gastro-oesophagial disease in SSC | systemic sclerosis | acotinamaide hydrpchloride 100 mg tablets, 3 times/day, 28 days trimebutine maleateon 100 mg tablets, 3 times/day, 28 days | Third Department of Internal Medicine (Department of Rheumatology) Shimane University Faculty of Medicine | Japanese Cross Society Matsue JCS HospitalShimane Prefecture central Hospital | Pending | 20years-old | Not applicable | Male and Female | 40 | Phase 3 | Japan |